EZH2 and gastric cancer: Statistical analyses revealed that Ezh2 mRNA expression strongly correlated with the tumor size (P = 0.003), lymphatic invasion (P = 0.019), and TNM stage (P = 0.016), indicating that Ezh2 overexpression is associated with the clinical progression of human GC.